Welcome

The University of Illinois at Chicago Transplant Center provides an innovative approach to organ transplantation.  The renowned program offers state-of-the-art kidney, liver, kidney-pancreas, isolated pancreas, small bowel, and islet cell transplantation services.  Our multidisciplinary transplant team is dedicated to providing optimal healthcare to its patients, treating each individual with compassion, dignity and respect.  Our ultimate goal is to give each patient a chance to live a longer, healthier, more fulfilling life. 
Our multidisciplinary team includes experts in the following fields:

Established in 1968, the department’s pioneer spirit has sustained the transplant program for almost 40 years, motivating unique and advanced procedures that stand as landmarks in the history of transplantation.

Fast Facts

• First living donor kidney-pancreas transplant in Illinois (1997)
• First adult-to-adult living donor liver transplant in US (1998)
• First coronary artery bypass and liver transplant in the same setting (1998)
• First adult living donor bowel transplant in Illinois (1998)
• First robotic donor nephrectomy for living donor kidney transplant in the world (2000)
• First liver and small bowel transplants from same living donor into same recipient worldwide (2004)
• First combined living donor liver-bowel transplant in the world (2005)
• First robotic hepatectomy in the US (2005)
• First paired donation in Illinois for ABO incompatible kidney transplant (2006)
• First robotic donor pancreatectomy for living donor pancreas transplant in the world (2006)
• Largest experience in Illinois with ABO Incompatible and Cross Match Positive in living donor kidney transplant
• Largest living donor intestinal transplant program worldwide
• One of two programs worldwide offering living donors for the abdominal organs: kidney liver, pancreas, intestine, combined liver/bowel, combined kidney/pancreas
• Only program offering combined living donor transplant from parent to child less than five years of age
• First Phase 3 trial in Islet Transplantation in United States
  
  

Expertise

• Highly sensitized patients
• Largest Program in country in minority
• +  cross match and ABO incompatible donors
• Highly experienced transplant surgeons utilizing state of the art technology
• E.g. Robotics
• Expertise in immunosuppression pharmacology
• Islet Transplantation
• Intestinal Transplantation
• Liver Transplantation